ELUT FY 2021 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$47M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$47M+11.0% YoY

Gross Profit

$19M40.1% margin

Operating Income

-$23M-48.6% margin

Net Income

-$25M-52.4% margin

EPS (Diluted)

$-2.38

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$16M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$67M

Total Liabilities

$54M

Stockholders' Equity

$14M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47M	$43M	+11.0%
Gross Profit	$19M	$21M	-7.5%
Operating Income	-$23M	-$14M	-69.4%
Net Income	-$25M	-$22M	-13.8%